Hans Ibsen

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen et al. · The Lancet · 2002 · 5.4K citations

Medicine, Cardiology, Internal Medicine +13

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Lars Lindholm, Hans Ibsen, Björn Dahlöf et al. · The Lancet · 2002 · 1.6K citations

Medicine, Cardiology, Internal Medicine +15

Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population

Tine W. Hansen, Jan A. Staessen, Christian Torp‐Pedersen et al. · Circulation · 2006 · 1.5K citations · Full text

Medicine, Cardiology, Clinical Epidemiology +16

Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study

José Boggia, Yan Li, Lutgarde Thijs et al. · The Lancet · 2007 · 873 citations · Full text

Medicine, Cardiology, Nephrology +14

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol

Kristian Wachtell, Mika Lehto, Eva Gerdts et al. · Journal of the American College of Cardiology · 2005 · 827 citations

Medicine, Cardiology, Pharmacology +12